These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8721949)

  • 1. Absence of the Gly40-Ser mutation in the glucagon receptor among diabetic patients in the Netherlands.
    Hart LM; Stolk RP; Jansen JJ; Grobbee DE; Lemkes HH; Maassen JA
    Diabetes Care; 1995 Oct; 18(10):1400-1. PubMed ID: 8721949
    [No Abstract]   [Full Text] [Related]  

  • 2. Absence of association between the Gly40-->Ser mutation in the human glucagon receptor and Japanese patients with non-insulin-dependent diabetes mellitus or impaired glucose tolerance.
    Odawara M; Tachi Y; Yamashita K
    Hum Genet; 1996 Dec; 98(6):636-9. PubMed ID: 8931690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of the Gly40-ser mutation in the glucagon receptor gene in Japanese subjects with NIDDM.
    Ogata M; Iwasaki N; Ohgawara H; Karibe S; Omori Y
    Diabetes Res Clin Pract; 1996 Jul; 33(2):71-4. PubMed ID: 8879960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mutation in the glucagon receptor gene (Gly40Ser): heterogeneity in the association with diabetes mellitus.
    Fujisawa T; Ikegami H; Yamato E; Takekawa K; Nakagawa Y; Hamada Y; Ueda H; Fukuda M; Ogihara T
    Diabetologia; 1995 Aug; 38(8):983-5. PubMed ID: 7589886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gly40Ser substitution in the glucagon receptor is rarely involved in the pathogenesis of NIDDM in Japanese patients.
    Odawara M; Matsunuma A; Yamashita K
    Diabetes Care; 1996 May; 19(5):547. PubMed ID: 8732726
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of association between the Gly40Ser polymorphism in the glucagon receptor gene and NIDDM in Finland.
    Huang X; Orho M; Lehto M; Groop L
    Diabetologia; 1995 Oct; 38(10):1246-8. PubMed ID: 8690179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Gly40Ser mutation in the human glucagon receptor gene associated with NIDDM results in a receptor with reduced sensitivity to glucagon.
    Hansen LH; Abrahamsen N; Hager J; Jelinek L; Kindsvogel W; Froguel P; Nishimura E
    Diabetes; 1996 Jun; 45(6):725-30. PubMed ID: 8635644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the Gly40Ser polymorphism in the glucagon receptor gene in a German non-insulin-dependent diabetes mellitus population.
    Ambrosch A; Lobmann R; Dierkes J; König W; Luley C; Lehnert H
    Clin Chem Lab Med; 1999 Jul; 37(7):719-21. PubMed ID: 10510728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation of the glucagon receptor gene and diabetes mellitus in the UK: association or founder effect?
    Gough SC; Saker PJ; Pritchard LE; Merriman TR; Merriman ME; Rowe BR; Kumar S; Aitman T; Barnett AH; Turner RC
    Hum Mol Genet; 1995 Sep; 4(9):1609-12. PubMed ID: 8541847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon receptor gene mutation in NIDDM.
    Jaksch M; Hofmann S; Gerbitz KD
    Diabetologia; 1996 Feb; 39(2):248. PubMed ID: 8635682
    [No Abstract]   [Full Text] [Related]  

  • 11. Influence of family history on frequency of glucagon receptor Gly40Ser mutation in hypertensive subjects.
    Morris BJ; Jeyasingam CL; Zhang W; Curtain RP; Griffiths LR
    Hypertension; 1997 Dec; 30(6):1640-1. PubMed ID: 9403595
    [No Abstract]   [Full Text] [Related]  

  • 12. A missense mutation in the glucagon receptor gene is associated with non-insulin-dependent diabetes mellitus.
    Hager J; Hansen L; Vaisse C; Vionnet N; Philippi A; Poller W; Velho G; Carcassi C; Contu L; Julier C
    Nat Genet; 1995 Mar; 9(3):299-304. PubMed ID: 7773293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of mitochondrial DNA tRNA leucine and glucagon receptor missense mutations in Utah white diabetic patients.
    Elbein SC; Hoffman MD
    Diabetes Care; 1996 May; 19(5):507-8. PubMed ID: 8732719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphism of the glucagon receptor gene and non-insulin-dependent diabetes mellitus in the Russian population.
    Babadjanova G; Reincke M; Mora P; Chuchalin A; Allolio B
    Exp Clin Endocrinol Diabetes; 1997; 105(4):225-6. PubMed ID: 9285210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon receptor Gly40Ser amino acid variant in Sardinian hypertensive non-insulin-dependent diabetic patients. Sardinian Diabetic Genetic Study Group (SDGSG).
    Tonolo G; Melis MG; Ciccarese M; Secchi G; Atzeni MM; Li LS; Luthman H; Maioli M
    Acta Diabetol; 1997 Aug; 34(2):75-6. PubMed ID: 9325468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glucagon-like peptide-1 (GLP-1) receptor gene].
    Taminato T; Yagi T; Nishi S
    Nihon Rinsho; 1997 Oct; 55 Suppl():432-6. PubMed ID: 9392144
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glucagon receptor gene].
    Inoue H; Oka Y
    Nihon Rinsho; 1997 Oct; 55 Suppl():429-31. PubMed ID: 9392143
    [No Abstract]   [Full Text] [Related]  

  • 18. [Gly40Ser mutation of glucagon receptor gene and NIDDM in Han nationality].
    Deng H; Tang WL; Pan Q
    Hunan Yi Ke Da Xue Xue Bao; 2001 Aug; 26(4):291-3. PubMed ID: 12536714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypothesis: glucagon receptor glycine to serine missense mutation contributes to one in 20 cases of essential hypertension.
    Morris BJ; Chambers SM
    Clin Exp Pharmacol Physiol; 1996 Dec; 23(12):1035-7. PubMed ID: 8977155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A population association study of four candidate genes (hexokinase II, glucagon-like peptide-1 receptor, fatty acid binding protein-2, and apolipoprotein C-II) with type 2 diabetes and impaired glucose tolerance in Japanese subjects.
    Yagi T; Nishi S; Hinata S; Murakami M; Yoshimi T
    Diabet Med; 1996 Oct; 13(10):902-7. PubMed ID: 8911786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.